Korea Joongang Daily on MSN40m
Celltrion's Actemra biosimilar gets FDA approvalCelltrion's biosimilar Avtozma, used to treat inflammatory diseases, was approved for the U.S. market by the Food and Drug Administration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback